Metformin, first drug of choice in the treatment of T2DM, induced a significant increase of GLP-1(7–36) amide/(7–37) at 30 and 60 min after the oral glucose load in obese nondiabetic subjects. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.